Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3

Structure

Volumn 24, Issue 11, 2016, Pages 2016-2023

  Liu, Weifeng ^a   Ramagopal, Udupi ^a   Cheng, Huiyong ^a   Bonanno, Jeffrey B ^a   Toro, Rafael ^a   Bhosle, Rahul ^a   Zhan, Chenyang ^a   Almo, Steven C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECOY RECEPTOR 3; FAS LIGAND; TUMOR NECROSIS FACTOR; FAS ANTIGEN; FAS PROTEIN, HUMAN; FASLG PROTEIN, HUMAN; HERPESVIRUS ENTRY MEDIATOR LIGAND; PROTEIN BINDING; RECOMBINANT PROTEIN; TNFRSF6B PROTEIN, HUMAN; TNFSF14 PROTEIN, HUMAN; TNFSF15 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

APOPTOSIS; ARTICLE; CRYSTAL STRUCTURE; HUMAN; JURKAT CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; BINDING SITE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENETICS; GLYCOSYLATION; METABOLISM; MOLECULAR MODEL; MUTATION; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

ANTIGENS, CD95; APOPTOSIS; BINDING SITES; CELL SURVIVAL; CRYSTALLOGRAPHY, X-RAY; FAS LIGAND PROTEIN; GLYCOSYLATION; HUMANS; JURKAT CELLS; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84993977943     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2016.09.009     Document Type: Article

References (22)

1. Bai, C., Connolly, B., Metzker, M.L., Hilliard, C.A., Liu, X., Sandig, V., Soderman, A., Galloway, S.M., Liu, Q., Austin, C.P., Caskey, C.T., Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl. Acad. Sci. USA 97 (2000), 1230–1235.
2. Hao, Z., Duncan, G.S., Seagal, J., Su, Y.W., Hong, C., Haight, J., Chen, N.J., Elia, A., Wakeham, A., Li, W.Y., et al. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 29 (2008), 615–627.
3. Holler, N., Tardivel, A., Kovacsovics-Bankowski, M., Hertig, S., Gaide, O., Martinon, F., Tinel, A., Deperthes, D., Calderara, S., Schulthess, T., Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol. Cell Biol. 23 (2003), 1428–1440.
4. Janssen, O., Qian, J., Linkermann, A., Kabelitz, D., CD95 ligand–death factor and costimulatory molecule?. Cell Death Differ. 10 (2003), 1215–1225.
5. Liu, W., Zhan, C., Cheng, H., Kumar, P.R., Bonanno, J.B., Nathenson, S.G., Almo, S.C., Mechanistic basis for functional promiscuity in the TNF and TNF receptor superfamilies: structure of the LIGHT: DcR3 assembly. Structure 22 (2014), 1252–1262.
6. Liu, W., Vigdorovich, V., Zhan, C., Patskovsky, Y., Bonanno, J.B., Nathenson, S.G., Almo, S.C., Increased heterologous protein expression in Drosophila s2 cells for massive production of immune ligands/receptors and structural analysis of human HVEM. Mol. Biotechnol. 57 (2015), 914–922.
7. Pitti, R.M., Marsters, S.A., Lawrence, D.A., Roy, M., Kischkel, F.C., Dowd, P., Huang, A., Donahue, C.J., Sherwood, S.W., Baldwin, D.T., et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396 (1998), 699–703.
8. Pryor, N.E., Moss, M.A., Hestekin, C.N., Unraveling the early events of amyloid-beta protein (Abeta) aggregation: techniques for the determination of Abeta aggregate size. Int. J. Mol. Sci. 13 (2012), 3038–3072.
9. Rao, V.K., Oliveira, J.B., How I treat autoimmune lymphoproliferative syndrome. Blood 118 (2011), 5741–5751.
10. Riedl, S.J., Shi, Y., Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5 (2004), 897–907.
11. Schneider, P., Bodmer, J.L., Holler, N., Mattmann, C., Scuderi, P., Terskikh, A., Peitsch, M.C., Tschopp, J., Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J. Biol. Chem. 272 (1997), 18827–18833.
12. Schreiber, T.H., Podack, E.R., Immunobiology of TNFSF15 and TNFRSF25. Immunol. Res. 57 (2013), 3–11.
13. Siegel, R.M., Chan, F.K., Chun, H.J., Lenardo, M.J., The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1 (2000), 469–474.
14. Starling, G.C., Bajorath, J., Emswiler, J., Ledbetter, J.A., Aruffo, A., Kiener, P.A., Identification of amino acid residues important for ligand binding to Fas. J. Exp. Med. 185 (1997), 1487–1492.
15. Strasser, A., Jost, P.J., Nagata, S., The many roles of FAS receptor signaling in the immune system. Immunity 30 (2009), 180–192.
16. Sudhamsu, J., Yin, J., Chiang, E.Y., Starovasnik, M.A., Grogan, J.L., Hymowitz, S.G., Dimerization of LTbetaR by LTalpha1beta2 is necessary and sufficient for signal transduction. Proc. Natl. Acad. Sci. USA 110 (2013), 19896–19901.
17. Voss, M., Lettau, M., Paulsen, M., Janssen, O., Posttranslational regulation of Fas ligand function. Cell Commun. Signal., 6, 2008, 11.
18. Wajant, H., The Fas signaling pathway: more than a paradigm. Science 296 (2002), 1635–1636.
19. Wang, L., Yang, J.K., Kabaleeswaran, V., Rice, A.J., Cruz, A.C., Park, A.Y., Yin, Q., Damko, E., Jang, S.B., Raunser, S., et al. The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat. Struct. Mol. Biol. 17 (2010), 1324–1329.
20. Ward-Kavanagh, L.K., Lin, W.W., Šedý, J.R., Ware, C.F., The TNF receptor superfamily in co-stimulating and co-inhibitory responses. Immunity 44 (2016), 1005–1019.
21. You, R.I., Chang, Y.C., Chen, P.M., Wang, W.S., Hsu, T.L., Yang, C.Y., Lee, C.T., Hsieh, S.L., Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3). Blood 111 (2008), 1480–1488.
22. Zhan, C., Patskovsky, Y., Yan, Q., Li, Z., Ramagopal, U., Cheng, H., Brenowitz, M., Hui, X., Nathenson, S.G., Almo, S.C., Decoy strategies: the structure of TL1A: DcR3 complex. Structure 19 (2011), 162–171.